Quidel Corporation (QDEL) |
|
189.31 18.56 (10.87%)
|
09-20 21:02 |
|
Open: |
174.48 |
Pre. Close: |
170.75 |
|
High:
|
191.58 |
Low:
|
169.58 |
|
Volume:
|
2,384,712 |
Market Cap:
|
8,426M |
|
|
|
|
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. The company is headquartered in San Diego, California and currently employs 1,224 full-time employees. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The firm sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women's health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The firm provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, MicroVue, FreshCells, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, Amplivue, Lyra and Thyretain. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
191.599 - 192.266 |
192.266 - 192.877 |
|
Low:
|
167.833 - 168.615 |
168.615 - 169.331 |
|
Close:
|
187.947 - 189.146 |
189.146 - 190.243 |
|
Technical analysis |
as of: 2020-09-18 4:34:52 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 243.10  One year: 295.89 |
| Support: |
Support1: 135.02 Support2: 112.34 |
| Resistance: |
Resistance1: 208.14 Resistance2: 253.33 |
| Pivot: |
162.82  |
| Moving Average: |
MA(5): 169.32 MA(20): 177.12
MA(100): 204.81 MA(250): 127.98 |
| MACD: |
MACD(12,26): -16.54 Signal(9): -20.61 |
| Stochastic oscillator: |
%K(14,3): 67.21 %D(3): 46.20 |
| RSI: |
RSI(14): 50.07 |
| 52-week: |
High: 306.72 Low: 55.25 Change(%): 199.3 |
| Average Vol(K): |
3-Month: 130028 10-Days: 117124 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.QDEL has closed It is unclear right now based on current numbers. 47.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to QDEL's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Fri, 18 Sep 2020
Quidel Corporation [QDEL] gain 127.58% so far this year. What now? - The DBT News
Mon, 14 Sep 2020
Hedge Funds Have Never Been This Bullish On Quidel Corporation (QDEL) - Yahoo Finance
Mon, 14 Sep 2020
Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Fri, 11 Sep 2020
Quidel Enters Oversold Territory - Yahoo Finance
Wed, 02 Sep 2020
Quidel Corporation [QDEL] gain 111.08% so far this year. What now? - The DBT News
Wed, 02 Sep 2020
Quidel: Bad News Is Sometimes No News At All - Seeking Alpha
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
42 |
| Shares Float (M) |
38 |
|
% Held by Insiders
|
11.89 |
|
% Held by Institutions
|
91.59 |
|
Shares Short (K)
|
2,070 |
|
Shares Short P. Month (K)
|
1,860 |
Stock Financials |
|
EPS
|
3.550 |
|
EPS Est This Year
|
0.290 |
|
EPS Est Next Year
|
1.260 |
|
Book Value (p.s.)
|
14.580 |
|
Profit Margin
|
23.61 |
|
Operating Margin
|
31.01 |
|
Return on Assets (ttm)
|
14.0 |
|
Return on Equity (ttm)
|
27.6 |
|
Qtrly Rev. Growth
|
86.4 |
|
Gross Profit (p.s.)
|
7.647 |
|
Sales Per Share
|
15.616 |
|
EBITDA (p.s.)
|
6.056 |
|
Qtrly Earnings Growth
|
5226.90 |
|
Operating Cash Flow (M)
|
181 |
|
Levered Free Cash Flow (M)
|
134 |
Stock Valuations |
|
PE Ratio
|
53.33 |
|
PEG Ratio
|
|
|
Price to Book value
|
12.98 |
|
Price to Sales
|
12.12 |
|
Price to Cash Flow
|
43.82 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
